1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets

  • August 2014
  • 508 pages
  • ID: 2313351

Summary

Table of Contents

This report elaborates on the present landscape for major segments of the GPCR drug market, discusses and relates the future trends and strategies to the breakthrough developments within the market. The estimations for the period between 2013 and 2018 are applied on the sales figures for the global and regional market forecasting.

Use this report to:
- Gain in detail information about the GPCR market by disease type as well as by drug group.
- Analyze prospects in the pipeline for GPCR targeting drugs.
- Learn about the key drivers and limiting factors as well as major threats versus opportunities for the future growth and direction of the GPCR market.

Highlights
- The global G protein, coupled receptors (GPCR) targeting drug market sharply fell in the last three years due to a series of patent expirations of blockbuster products. The market receded from nearly $111 billion to almost $100 billion with a -3.4% compound annual growth rate (CAGR) between 2010 and 2013. With the introduction of novel pharmacecuticals and newly appearing classes of drugs, BCC Research expects this market to reach $114 billion by 2018, a CAGR of 2.7% from 2013 to 2018.
- The US market was $48.1 billion in 2012. This market is predicted to decrease to $44.5 billion by 2013. With a CAGR of 2.0% from 2013 to 2018, it is expected that the market would recover and reach $49.1 billion by 2018.
- The BRIC market achieved a positive CAGR during the previous three years and increased its market share to nearly $8 billion by 2013. With a CAGR of 5.4% from 2013 to 2018, BCC Research estimates this market to reach $10.3 billion by 2018.

Introduction & Scope
INTRODUCTION
STUDY OBJECTIVES
The aim of this work is to study the global market for G Protein Coupled Receptor, or GPCR-targeting drugs, and to provide beneficial information on the current and future
participators that determine the market’s short-term directions.

This report elaborates on the present landscape for major segments of the GPCR drug market, which includes three extensive sets of drug groups under Class A, B and C
GPCR-targeting drugs; and furthermore, the report discusses and relates the future trends and strategies to the breakthrough developments within the market. The key drivers and limiting factors as well as major threats versus opportunities for the future growth and direction of the market were identified and addressed within this
report. The classification and comparison of the distinct segments of the GPCR drugs were performed and conveyed via the report, along with the anticipated extensions to
these segments.

The industry dynamics and characteristics were analyzed and utilized for the interpretation and forecasting for the overall GPCR drugs. The obtained revenues for the majority of the indicated products constituting the market were collected and broken down by region. The estimations for the period between 2013 and 2018 were applied on the sales figures for the global and regional market forecasting. The report also sheds light on the therapeutic applications of the marketed GPCR drugs; the breakdown by therapeutic applications was accomplished under eight main groups and multiple subgroups. The regulatory views on the marketed and in-development products were also mentioned through the recent approvals and enforced safety measures for the product manufacturers.

REASONS FOR DOING THE STUDY
The recent technological advances and accumulating structural and functional literature on the physiological and pharmacological features of the GPCRs have shown that these targets have versatile utilities in the treatment of a broad spectrum of diseases across almost every therapeutic area. The multitude of the untapped orphan GPCR targets and the previously undruggable targets that are becoming viable just recently attracted companies from various backgrounds of specialties and expertise to invest more in the research and development of the GPCR drugs.

Innovation and improvement are the offsetting factors for the effects of the ongoing patent expirations and concentrated regression of market sub-segments following peak
years of sales. The innovations under existing and newly appearing market segments were provided in the report; trends for improvement and seizable market opportunities
were mentioned under therapeutic applications.

INTENDED AUDIENCE
This study adds value to the processes of the discovery, development and commercialization of the GPCR-targeting drugs. Pharmaceutical and biotechnology companies, research institutes and healthcare professionals, large companies and small to medium-size enterprises will find this report to be of great utility.

SCOPE OF THE STUDY
The scope of this study encompasses the GPCR targeting drugs in pharmaceutical and biopharmaceutical markets. BCC Research analyzed each market and its applications,
regulatory environment, technology, market projections and market share. Technological issues include the latest trends and developments. The strong growing market for the GPCR drugs includes the countries of the EU such as the U.K., France, Germany, Spain and Italy, and also include the emerging countries such as China, Brazil, South Korea, Taiwan, Mexico and other countries.

METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research were conducted and used in preparing this study. The analyst of the report conducted a comprehensive literature search from public,
private and government sources, which included company publications, industrial and market reports available in physical or electronic format, research papers, scientific
journals and various other professionally written dedicated sources; as well as industrial databases, company and product literature.

Data were obtained through interviews and correspondence with the research-based companies and technical experts of the GPCR-based drug lead discovery. Projections were based on estimates such as the current number of end users, potential end users, market entry products, patent expirations, regional dynamics, disease prevalence and other market trends.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Lab Automation Market by Equipment and Software, Applications, End Users - Global Forecast to 2022

Lab Automation Market: Global Forecast until 2022

  • $ 5650
  • Industry report
  • November 2017
  • by MarketsandMarkets

“The global lab automation market is projected to grow at a CAGR of 5.1%.”The lab automation market is expected to reach USD 5.20 billion by 2022 from an estimated USD 4.06 billion in 2017, at a CAGR ...

Cell Based Assays Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

Cell Based Assays Industry: Forecasts to 2022

  • $ 5795
  • Industry report
  • September 2017
  • by Transparency Market Research

Global Cell Based Assays Market: OverviewThis report on the global cell based assays market analyzes the current and future scenario of the global market. rising incidence of chronic diseases, growing ...

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • $ 4000
  • Industry report
  • October 2017
  • by GlobalData

Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, 2017SummaryGlobalData’s Medical Devices sector report, “Hepatitis Viruses Diagnostic Tests - Medical Devices Pipeline Assessment, ...

Genetic Testing in Italy to 2024 $ 4995 November 2017


ref:plp2014

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.